By API User
A new research team at XSeed Labs – a collaboration between BioMed X and Boehringer Ingelheim, will develop disease models to understand wound healing and fibrosis. RIDGEFIELD, CT / ACCESSWIRE / May 16, 2024 / XSeed Labs – a collaboration between BioMed X and Boehringer Ingelheim, announces the start of its first research team on … Continued
By API User
"Nando", a leading Lithuanian-owned biotechnology company known for its groundbreaking work in developing microbiological products for agriculture, that helped to save up to 50M on fertilisers, announces a significant bolstering of its management team and an ambitious expansion of its biotechnological production line. This move is set to position "Nando" not just as a leader … Continued
By API User
Melbourne, 7th May, 2024 CUREator by Brandon BioCatalyst has announced the deployment of $7.21 million in funding to support eight biotech companies across their Clinical and Preclinical streams thanks to the Federal Government’s Medical Research Future Fund’s Early-Stage Translation and Commercialisation Support (ESTAC) grant. This latest round of the competitive commercial grant funding … Continued
By API User
Sydney, Australia, Wednesday, 1 May 2024 – Illumina, Inc. (NASDAQ: ILMN) Embargo and media call: 10 am, Garvan Institute, 384 Victoria St, Darlinghurst NSW With researchers, The Hon. David Harris MP, NSW Minister for Medical Research, and Madeleine Jandura who was diagnosed with ulcerative colitis at age 11. Illumina, a global genomics and human health … Continued
By API User
LUXEMBOURG / ACCESSWIRE / April 30, 2024 / Moolec Science SA (NASDAQ:MLEC) ("Company"; "Moolec"), a Molecular Farming food-ingredient company, announced today the granting of a patent family in the United States for its SPC2 product produced in safflower with Molecular Farming technology. This new patent adjudication will give the company, through its U.S. sole-owned subsidiary … Continued
By API User
The project is aimed at developing novel approaches to enhance tumor immunogenicity to broaden the population of patients who can benefit from cancer immunotherapy. HEIDELBERG, GERMANY / ACCESSWIRE / April 30, 2024 / BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site … Continued
By API User
TEWKSBURY, MA / ACCESSWIRE / April 25, 2024 / Cambridge Isotope Laboratories, Inc. (CIL) has acquired an additional 14.8 acres of land at its Cambridge Isotope Separations (CIS) Xenia, Ohio location. Mike Steiger, Vice President of Engineering and Project Execution for CIL, stated that the new land purchase will ensure easier access to utilities for … Continued
By API User
LUXEMBOURG / ACCESSWIRE / April 22, 2024 / Moolec Science SA (NASDAQ:MLEC)("The company"), a Molecular Farming food-ingredient company, announced today that the Animal and Plant Health Inspection Service ("APHIS") of the U.S. Department of Agriculture ("USDA") has concluded its Regulatory Status Review ("RSR") for Moolec’s genetically engineered ("GE") soybean Piggy Sooy™. See post online here: … Continued
By API User
Wilderlands have reached a major milestone becoming the world’s fastest voluntary biodiversity credit developer to retire over 100,000 units which will protect over 10 hectares of vulnerable Australian habitat, forever. The announcement was made at an event this week with over 100 leaders gathering at the University of Melbourne’s innovation precinct Melbourne Connect for … Continued
By API User
VANCOUVER, British Columbia, April 17, 2024 (GLOBE NEWSWIRE) — The rates of precancerous skin conditions and skin cancers are soaring in many parts of the world. Actinic keratosis (AK) is the most common form of precancer, with over 40 million Americans a year developing this condition. Treating AKs before the cells become cancerous and spread to other parts of the body is crucial. For those patients with multiple AKs, common treatment options are … Continued
